10x Genomics, Inc.

10x Genomics, Inc. is a life sciences technology company that builds products and solutions to analyze biological systems. The company's integrated research solutions include instruments, consumables, and software. These products allow customers to analyze biological systems at a high resolution and scale, enabling discoveries in areas such as oncology, immunology, and neuroscience. Since mid-2015 through December 31, 2025, 10x Genomics, Inc. has sold 8,046 instruments globally to academic and translational researchers and biopharmaceutical companies. The company's revenue was $642.8 million for the year ended 2025, an increase of 5% from $610.8 million in 2024. Net losses were $43.5 million in 2025 and $182.6 million in 2024. In 2025, the company sold 1,007 instruments and 424,000 consumable reactions, compared to 1,073 instruments and 357,100 consumable reactions in 2024. Over 10,000 peer-reviewed articles have been published using data generated with their products. The company's products focus on enabling understanding biology at the single cell level or at high spatial resolution of tissues and organs, and can measure millions of single cells or tissue sample positions.